Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Makino

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|March 26, 2018
Strategic R&D transactions in personalized drug developmentTomohiro Makino, Yeongjoo Lim, Kota Kodama
Microbial Cell Factories|May 17, 2011
Strain engineering for improved expression of recombinant proteins in bacteriaTomohiro Makino, Georgios Skretas, George Georgiou
Methods in Enzymology|September 15, 2012
Synthesis of ghrelin: chemical synthesis and semisynthesis for large-scale preparation of modified peptidesTomohiro Makino, Masaru Matsumoto, Yoshiharu Minamitake
Drug Discovery Today|October 20, 2018
Trends in interorganizational transactions in personalized medicine developmentTomohiro Makino, Shintaro Sengoku, Shuichi Ishida, et al.
Metabolic Engineering|December 7, 2010
Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodiesTomohiro Makino, Georgios Skretas, Tae-Hyun Kang, et al.
Journal of Bioscience and Bioengineering|June 3, 2018
Development of a novel immunoassay to select antibodies against intact membrane antigens by using the homogeneous AlphaLISA systemSatoshi Muneoka, Ryuichi Nakamura, Masato Hoshino, et al.
Metabolic Engineering|May 22, 2012
Multi-copy genes that enhance the yield of mammalian G protein-coupled receptors in Escherichia coliGeorgios Skretas, Tomohiro Makino, Navin Varadarajan, et al.
Drug Discovery Today|November 30, 2019
Holistic cost-effectiveness analysis of anticancer drug regimens in JapanFumio Teramae, Naoya Yamaguchi, Tomohiro Makino, et al.
Journal of Personalized Medicine|June 2, 2021
Dynamic Collaborations for the Development of Immune Checkpoint Blockade AgentsArisa Djurian, Tomohiro Makino, Yeongjoo Lim, et al.
Scientific Reports|September 29, 2025
Selective agonists of KIR and NKG2A to evade missing self response of natural killer cellsSatoshi Hiura, Yuto Kuwasaki, Yosuke Nishikawa, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|March 26, 2018
Strategic R&D transactions in personalized drug developmentTomohiro Makino, Yeongjoo Lim, Kota Kodama
Microbial Cell Factories|May 17, 2011
Strain engineering for improved expression of recombinant proteins in bacteriaTomohiro Makino, Georgios Skretas, George Georgiou
Methods in Enzymology|September 15, 2012
Synthesis of ghrelin: chemical synthesis and semisynthesis for large-scale preparation of modified peptidesTomohiro Makino, Masaru Matsumoto, Yoshiharu Minamitake
Drug Discovery Today|October 20, 2018
Trends in interorganizational transactions in personalized medicine developmentTomohiro Makino, Shintaro Sengoku, Shuichi Ishida, et al.
Metabolic Engineering|December 7, 2010
Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodiesTomohiro Makino, Georgios Skretas, Tae-Hyun Kang, et al.
Journal of Bioscience and Bioengineering|June 3, 2018
Development of a novel immunoassay to select antibodies against intact membrane antigens by using the homogeneous AlphaLISA systemSatoshi Muneoka, Ryuichi Nakamura, Masato Hoshino, et al.
Metabolic Engineering|May 22, 2012
Multi-copy genes that enhance the yield of mammalian G protein-coupled receptors in Escherichia coliGeorgios Skretas, Tomohiro Makino, Navin Varadarajan, et al.
Drug Discovery Today|November 30, 2019
Holistic cost-effectiveness analysis of anticancer drug regimens in JapanFumio Teramae, Naoya Yamaguchi, Tomohiro Makino, et al.
Journal of Personalized Medicine|June 2, 2021
Dynamic Collaborations for the Development of Immune Checkpoint Blockade AgentsArisa Djurian, Tomohiro Makino, Yeongjoo Lim, et al.
Scientific Reports|September 29, 2025
Selective agonists of KIR and NKG2A to evade missing self response of natural killer cellsSatoshi Hiura, Yuto Kuwasaki, Yosuke Nishikawa, et al.
Pageof 2